Guardian Pharmacy Services Inc. Class A Common Stock (GRDN) fair value

ACCE thesis

Guardian Pharmacy Services runs institutional pharmacy programs for skilled nursing and assisted living facilities, dispensing and packaging medications under long-term contracts with those facilities. The moat is operational: contracts are sticky, the cost of switching a facility's medication management is high, and scale in regional dispensing networks compounds. Revenue growth of 2.2% is slow, so the thesis rests on margin and capital efficiency rather than top-line momentum; a 30.4% ROE on a 3.5% operating margin tells you the balance sheet is doing much of the work. At 38.5 trailing and 30.2 forward earnings, the stock is priced for earnings improvement, which makes the margin trajectory the variable to check first. Scored 61/100 and not in any major index, it is a small-cap healthcare services name worth a deeper look mainly if you can underwrite where operating margin goes from 3.5%.